世界の甲状腺がん治療市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV04851)
◆英語タイトル:Global Thyroid Cancer Treatment Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV04851
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:92
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは甲状腺がん治療の世界市場について調査・分析した資料です。種類別(手術、ヨウ素療法、体外照射療法、サイロキシン治療、化学療法、薬物)の市場規模、用途別(病院、腫瘍学センター、病院薬局、小売薬局)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別甲状腺がん治療の競争状況、市場シェア
・世界の甲状腺がん治療市場:種類別市場規模 2015年-2020年(手術、ヨウ素療法、体外照射療法、サイロキシン治療、化学療法、薬物)
・世界の甲状腺がん治療市場:種類別市場規模予測 2021年-2026年(手術、ヨウ素療法、体外照射療法、サイロキシン治療、化学療法、薬物)
・世界の甲状腺がん治療市場:用途別市場規模 2015年-2020年(病院、腫瘍学センター、病院薬局、小売薬局)
・世界の甲状腺がん治療市場:用途別市場規模予測 2021年-2026年(病院、腫瘍学センター、病院薬局、小売薬局)
・北米の甲状腺がん治療市場分析:米国、カナダ
・ヨーロッパの甲状腺がん治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの甲状腺がん治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の甲状腺がん治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの甲状腺がん治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Baxter、Mylan、Alara、Bristol Myers、Abbott、Teva、App pharmaceuticals、Jerome Stevens
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Thyroid Cancer Treatment Market
The global Thyroid Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Thyroid Cancer Treatment Scope and Market Size
Thyroid Cancer Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Thyroid Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Baxter
Mylan
Alara
Bristol Myers
Abbott
Teva
App pharmaceuticals
Jerome Stevens

Market segment by Type, the product can be split into
Surgery
Iodine Therapy
External Radiotherapy
Thyroxin Treatment
Chemotherapy
Drugs
Market segment by Application, split into
Hospitals
Oncology centers
Hospital Pharmacies
Retail Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Thyroid Cancer Treatment Revenue
1.4 Market by Type
1.4.1 Global Thyroid Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Iodine Therapy
1.4.4 External Radiotherapy
1.4.5 Thyroxin Treatment
1.4.6 Chemotherapy
1.4.7 Drugs
1.5 Market by Application
1.5.1 Global Thyroid Cancer Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Oncology centers
1.5.4 Hospital Pharmacies
1.5.5 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Thyroid Cancer Treatment Market Perspective (2015-2026)
2.2 Global Thyroid Cancer Treatment Growth Trends by Regions
2.2.1 Thyroid Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Thyroid Cancer Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Thyroid Cancer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Thyroid Cancer Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Thyroid Cancer Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Thyroid Cancer Treatment Players by Market Size
3.1.1 Global Top Thyroid Cancer Treatment Players by Revenue (2015-2020)
3.1.2 Global Thyroid Cancer Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Thyroid Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Thyroid Cancer Treatment Market Concentration Ratio
3.2.1 Global Thyroid Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Thyroid Cancer Treatment Revenue in 2019
3.3 Thyroid Cancer Treatment Key Players Head office and Area Served
3.4 Key Players Thyroid Cancer Treatment Product Solution and Service
3.5 Date of Enter into Thyroid Cancer Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Thyroid Cancer Treatment Historic Market Size by Type (2015-2020)
4.2 Global Thyroid Cancer Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Thyroid Cancer Treatment Market Size by Application (2015-2020)
5.2 Global Thyroid Cancer Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Thyroid Cancer Treatment Market Size (2015-2020)
6.2 Thyroid Cancer Treatment Key Players in North America (2019-2020)
6.3 North America Thyroid Cancer Treatment Market Size by Type (2015-2020)
6.4 North America Thyroid Cancer Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Thyroid Cancer Treatment Market Size (2015-2020)
7.2 Thyroid Cancer Treatment Key Players in Europe (2019-2020)
7.3 Europe Thyroid Cancer Treatment Market Size by Type (2015-2020)
7.4 Europe Thyroid Cancer Treatment Market Size by Application (2015-2020)

8 China
8.1 China Thyroid Cancer Treatment Market Size (2015-2020)
8.2 Thyroid Cancer Treatment Key Players in China (2019-2020)
8.3 China Thyroid Cancer Treatment Market Size by Type (2015-2020)
8.4 China Thyroid Cancer Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Thyroid Cancer Treatment Market Size (2015-2020)
9.2 Thyroid Cancer Treatment Key Players in Japan (2019-2020)
9.3 Japan Thyroid Cancer Treatment Market Size by Type (2015-2020)
9.4 Japan Thyroid Cancer Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Thyroid Cancer Treatment Market Size (2015-2020)
10.2 Thyroid Cancer Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Thyroid Cancer Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Thyroid Cancer Treatment Market Size by Application (2015-2020)

11 India
11.1 India Thyroid Cancer Treatment Market Size (2015-2020)
11.2 Thyroid Cancer Treatment Key Players in India (2019-2020)
11.3 India Thyroid Cancer Treatment Market Size by Type (2015-2020)
11.4 India Thyroid Cancer Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Thyroid Cancer Treatment Market Size (2015-2020)
12.2 Thyroid Cancer Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Thyroid Cancer Treatment Market Size by Type (2015-2020)
12.4 Central & South America Thyroid Cancer Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Baxter
13.1.1 Baxter Company Details
13.1.2 Baxter Business Overview
13.1.3 Baxter Thyroid Cancer Treatment Introduction
13.1.4 Baxter Revenue in Thyroid Cancer Treatment Business (2015-2020))
13.1.5 Baxter Recent Development
13.2 Mylan
13.2.1 Mylan Company Details
13.2.2 Mylan Business Overview
13.2.3 Mylan Thyroid Cancer Treatment Introduction
13.2.4 Mylan Revenue in Thyroid Cancer Treatment Business (2015-2020)
13.2.5 Mylan Recent Development
13.3 Alara
13.3.1 Alara Company Details
13.3.2 Alara Business Overview
13.3.3 Alara Thyroid Cancer Treatment Introduction
13.3.4 Alara Revenue in Thyroid Cancer Treatment Business (2015-2020)
13.3.5 Alara Recent Development
13.4 Bristol Myers
13.4.1 Bristol Myers Company Details
13.4.2 Bristol Myers Business Overview
13.4.3 Bristol Myers Thyroid Cancer Treatment Introduction
13.4.4 Bristol Myers Revenue in Thyroid Cancer Treatment Business (2015-2020)
13.4.5 Bristol Myers Recent Development
13.5 Abbott
13.5.1 Abbott Company Details
13.5.2 Abbott Business Overview
13.5.3 Abbott Thyroid Cancer Treatment Introduction
13.5.4 Abbott Revenue in Thyroid Cancer Treatment Business (2015-2020)
13.5.5 Abbott Recent Development
13.6 Teva
13.6.1 Teva Company Details
13.6.2 Teva Business Overview
13.6.3 Teva Thyroid Cancer Treatment Introduction
13.6.4 Teva Revenue in Thyroid Cancer Treatment Business (2015-2020)
13.6.5 Teva Recent Development
13.7 App pharmaceuticals
13.7.1 App pharmaceuticals Company Details
13.7.2 App pharmaceuticals Business Overview
13.7.3 App pharmaceuticals Thyroid Cancer Treatment Introduction
13.7.4 App pharmaceuticals Revenue in Thyroid Cancer Treatment Business (2015-2020)
13.7.5 App pharmaceuticals Recent Development
13.8 Jerome Stevens
13.8.1 Jerome Stevens Company Details
13.8.2 Jerome Stevens Business Overview
13.8.3 Jerome Stevens Thyroid Cancer Treatment Introduction
13.8.4 Jerome Stevens Revenue in Thyroid Cancer Treatment Business (2015-2020)
13.8.5 Jerome Stevens Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Baxter、Mylan、Alara、Bristol Myers、Abbott、Teva、App pharmaceuticals、Jerome Stevens

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の甲状腺がん治療市場2026:インサイト・予測(Global Thyroid Cancer Treatment Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。